Article
Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations.
Neurosurgical review - 1 Jan 2014
Schröder Winnie, Najm Juliane, Spiegler Stefanie, Mair Martina, Viera Julio, Henn Wolfram, Felbor Ute
Abstract excerpt
The mutation detection rate for familial cerebral cavernous malformations (CCM) is extremely high, being about 90 % if direct sequencing of the three genes, CCM1, CCM2, and CCM3, is used in conjunction with quantitative analyses to detect larger CCM1-3 deletions/duplications. We here report on an individual who had presented with more than 30 cerebral and spinal cavernous malformations, two intracranial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
